市場調査レポート

医薬品開発業務アウトソーシング(CRO)市場 - 世界の産業分析、サイズ、シェア、動向と予測

Healthcare Contract Research Outsourcing Market- Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018

発行 Transparency Market Research 商品コード 259904
出版日 ページ情報 英文 94 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
医薬品開発業務アウトソーシング(CRO)市場 - 世界の産業分析、サイズ、シェア、動向と予測 Healthcare Contract Research Outsourcing Market- Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
出版日: 2013年01月17日 ページ情報: 英文 94 Pages
概要

当レポートは、世界の医薬品開発業務アウトソーシング(CRO)市場に着目しその市場売上げと共に、市場動向、現在のシナリオと将来の動向を詳細に分析しています。市場は提供されるサービスに基づいた分類(臨床試験、薬事サービス、メディカルライティングサービス、臨床データ管理サービス)別、アウトソーシング先の研究グループに基づいた分類(開発業務受託機関(CRO)、治験研究所(CTL)、アカデミックメディカルセンター(AMC))別、地域に基いた分類(北米、欧州、アジアおよびその他の地域)別でそれぞれ分類され、各セグメントの詳細な傾向分析と、影響分析、傾向分析、市場の魅力度分析と共に、市場の促進要因、制約要因、機会を含む市場力学のような概念による市場分析や、関連する主な企業の概要、財務の概要、事業戦略、SWOT分析、最近の動向と製品ポートフォリオやこれら企業間の競争分析などを交え、概略下記内容でお届け致します。

第1章 はじめに

  • 本レポートの説明
  • 調査範囲
  • 調査方法

第2章 エグゼクティブサマリー

第3章 世界の医薬品開発業務アウトソーシング市場分析

  • 概要
  • 市場促進要因
    • 増加するコストと生産性の減少
    • 特許切れ
    • 新薬の研究開発を減らす(R&D)
    • 次世代治療法の選択肢として生物学的治療法が出現
    • 医薬品開発プロセスのグローバリゼーション
  • 市場制約要因
    • 国によって異なる規制ガイドラインおよび承認プロセス
    • 品質課題
    • 多様な遺伝と疾患プロファイル
    • 不測の費用
    • データの機密性の課題
    • 信頼性とサービスの停止
  • 市場機会
    • 増加する新興国での臨床試験
    • 増加する規制、臨床データ管理とメディカルライティング活動のアウトソーシング
  • 第4章 サービス別の世界の医薬品開発業務アウトソーシング市場
  • 概要
  • 臨床試験サービス
    • 創薬サービス
    • 前臨床サービス
    • 第I相試験サービス
    • 第II相試験サービス
    • 第III相試験サービス
    • 第IV相臨床試験(販売後サーベイランス)サービス
  • 規制サービス
  • メディカルライティングサービス
  • 臨床データ管理(CDM)サービス
  • その他

第5章 研究委託先別の世界の医薬品開発業務アウトソーシング

  • 概要
  • 開発業務受託機関(CRO)
  • 臨床試験研究所(CTL)
  • 学術医療センター(AMC)

第6章 地域別の世界の医薬品開発業務アウトソーシング市場

  • 概要
  • 北米
  • 欧州
  • アジア
  • その他の地域

第7章 競合展望

  • 概要
  • 主な企業の市場シェア
  • 主な企業の主要戦略
    • 研究サービス機能を拡充
    • 費用対効果の高いビジネスモデル
    • 熟練した研究人材を吸収

第8章 提言

  • 成功のための市場戦略
  • 考慮すべき障壁

第9章 企業プロファイル

目次

Abstract

Description

This report covers the market revenue for the global healthcare contract research outsourcing market. A detailed analysis of the market trends, current scenarios and future trends is available in the report. The market is analyzed by using concepts such as market dynamics including drivers, restraints and opportunities along with their impact analyses trend analysis, and market attractiveness analysis.

The market is segmented on the basis of services offered into: Clinical trials, regulatory services, medical writing services, clinical data management services. A detailed trend analysis of all the segments with a market evaluation in terms of revenue generated with respect to the applications and geography is available in this report. The market is segmented on the basis of the outsourcing destination research groups including Contract Research Organizations (CROs), Clinical Trial Laboratories (CTL), and Academic Medical Centers (AMCs)

The report also segments healthcare contract research outsourcing market based on geography into: North America, Europe, Asia and the rest of the world.

A competitive analysis of the market players involved is covered in the report. Some of the major players of this market include: Quintiles, Covance, PPD, Parexel, CRL, Icon, Plc. Medidata Solutions, InVentiv Health, Theorem Clinical research and others. Company overview, financial overview, business strategies, SWOT analysis, recent developments and product portfolio for each of the market player is also highlighted in the report.

The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the Contract research outsourcing market as below:

Global healthcare contract research outsourcing market by services

  • Clinical trial services
  • Drug discovery
  • Preclinical studies

Phase IV trial (Post marketing surveillance) services

  • Regulatory services
  • Medical writing services
  • Clinical data management (CDM) services
  • Regulatory services
  • Medical writing services
  • Clinical data management (CDM) services

Global healthcare contract research outsourcing market by destination research groups

  • Contract Research Organizations (CROs)
  • Clinical Trial Laboratories
  • Academic Medical Centers (AMCs)

Global healthcare contract research outsourcing market by Geography

  • North America
  • Europe
  • Asia
  • RoW

Table of Contents

CHAPTER 1 PREFACE

  • 1.1 REPORT DESCRIPTION
  • 1.2 RESEARCH METHODOLOGY

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET ANALYSIS

  • 3.1 OVERVIEW
  • 3.2 MARKET DRIVERS
    • 3.2.1 INCREASING COST AND REDUCING PRODUCTIVITY
    • 3.2.2 PATENT EXPIRATIONS
    • 3.2.3 DECREASING NEW DRUGS RESEARCH AND DEVELOPMENT (R&D)
    • 3.2.4 EMERGENCE OF BIOLOGICAL THERAPIES AS THE NEXT GENERATION TREATMENT OPTION
    • 3.2.5 GLOBALIZATION OF DRUG DEVELOPMENT PROCESS
  • 3.3 MARKET RESTRAINTS
    • 3.3.1 VARIATION IN REGULATORY GUIDELINES AND APPROVAL PROCESS IN DIFFERENT COUNTRIES
    • 3.3.2 QUALITY ISSUES
    • 3.3.3 GENETIC AND DISEASE PROFILE VARIATIONS
    • 3.3.4 UNFORESEEN COSTS
    • 3.3.5 DATA CONFIDENTIALITY ISSUES
    • 3.3.6 RELIABILITY AND SERVICE OUTAGES
  • 3.4 MARKET OPPORTUNITIES
    • 3.4.1 INCREASING CLINICAL TRIALS IN EMERGING COUNTRIES
    • 3.4.2 INCREASING OUTSOURCING OF REGULATORY, CLINICAL DATA MANAGEMENT AND MEDICAL WRITING ACTIVITIES

CHAPTER 4 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES

  • 4.1 OVERVIEW
  • 4.2 CLINICAL TRIAL SERVICES
    • 4.2.1 DRUG DISCOVERY SERVICES
    • 4.2.2 PRECLINICAL SERVICES
    • 4.2.3 PHASE I TRIAL SERVICES
    • 4.2.4 PHASE II TRIAL SERVICES
    • 4.2.5 PHASE III TRIAL SERVICES
    • 4.2.6 PHASE IV TRIAL (POST MARKETING SURVEILLANCE) SERVICES
  • 4.3 REGULATORY SERVICES
  • 4.4 MEDICAL WRITING SERVICES
  • 4.5 CLINICAL DATA MANAGEMENT (CDM) SERVICES
  • 4.6 OTHERS

CHAPTER 5 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING, BY DESTINATION RESEARCH GROUPS

  • 5.1 OVERVIEW
  • 5.2 CONTRACT RESEARCH ORGANIZATIONS (CROS)
    • 5.2.1 GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET REVENUE, BY SERVICES, 2010-2018 (USD BILLION)
  • 5.3 CLINICAL TRIAL LABORATORIES (CTL)
    • 5.3.1 GLOBAL CLINICAL TRIAL LABORATORIES OUTSOURCING MARKET REVENUE, BY SERVICES, 2010-2018 (USD BILLION)
  • 5.4 ACADEMIC MEDICAL CENTERS (AMCS)
    • 5.4.1 GLOBAL ACADEMIC MEDICAL CENTERS OUTSOURCING MARKET REVENUE, BY SERVICES, 2010-2018 (USD BILLION)

CHAPTER 6 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY GEOGRAPHY

  • 6.1 OVERVIEW
  • 6.2 NORTH AMERICA
    • 6.2.1 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION)
    • 6.2.2 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION)
    • 6.2.3 CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION)
  • 6.3 EUROPE
    • 6.3.1 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION)
    • 6.3.2 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION)
    • 6.3.3 CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION)
  • 6.4 ASIA
    • 6.4.1 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION)
    • 6.4.2 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION)
    • 6.4.3 CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION)
  • 6.5 REST OF WORLD
    • 6.5.1 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION)
    • 6.5.2 HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION)
    • 6.5.3 CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION)

CHAPTER 7 COMPETITIVE LANDSCAPE

  • 7.1 OVERVIEW
  • 7.2 MARKET SHARE BY KEY PLAYERS
  • 7.3 KEY STRATEGIES ADOPTED BY MAJOR PLAYERS
    • 7.3.1 EXPANDING RESEARCH SERVICE CAPABILITIES
    • 7.3.2 COST EFFECTIVE BUSINESS MODELS
    • 7.3.3 ABSORBING SKILLED RESEARCH PERSONNEL

CHAPTER 8 RECOMMENDATIONS

  • 8.1 MARKET STRATEGY FOR SUCCESS
  • 8.2 BARRIERS TO BE CONSIDERED

CHAPTER 9 COMPANY PROFILES

  • 9.1 QUINTILES TRANSNATIONAL CORPORATION
    • 9.1.1 COMPANY OVERVIEW
    • 9.1.2 FINANCIAL INFORMATION
    • 9.1.3 BUSINESS STRATEGIES
      • 9.1.3.1 Expansion of services
      • 9.1.3.2 Acquisitions and partnerships
      • 9.1.3.3 Innovation in services offered
    • 9.1.4 PRODUCT PORTFOLIO
    • 9.1.5 RECENT DEVELOPMENTS
  • 9.2 COVANCE, INC.
    • 9.2.1 OVERVIEW
    • 9.2.2 FINANCIAL INFORMATION
    • 9.2.3 BUSINESS STRATEGIES
      • 9.2.3.1 New product development and innovation
      • 9.2.3.2 Agreements and collaborations
    • 9.2.4 PRODUCT PORTFOLIO
    • 9.2.5 RECENT DEVELOPMENTS
  • 9.3 PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPD)
    • 9.3.1 COMPANY OVERVIEW
    • 9.3.2 FINANCIAL INFORMATION
    • 9.3.3 BUSINESS STRATEGIES
      • 9.3.3.1 New product launch and innovation
      • 9.3.3.2 Expanding geographic presence
    • 9.3.4 PRODUCT PORTFOLIO
    • 9.3.5 RECENT DEVELOPMENTS
  • 9.4 PAREXEL INTERNATIONAL CORPORATION
    • 9.4.1 COMPANY OVERVIEW
    • 9.4.2 FINANCIAL INFORMATION
    • 9.4.3 BUSINESS STRATEGIES
      • 9.4.3.1 Strong presence in Asia and emerging markets
      • 9.4.3.2 Strategic alliances
    • 9.4.4 PRODUCT PORTFOLIO
    • 9.4.5 RECENT DEVELOPMENTS
  • 9.5 CHARLES RIVER LABORATORIES INTERNATIONAL INC. (CRL)
    • 9.5.1 COMPANY OVERVIEW
    • 9.5.2 FINANCIAL INFORMATION
    • 9.5.3 BUSINESS STRATEGIES
      • 9.5.3.1 Business expansion in APAC region
      • 9.5.3.2 Expansion of services offered
      • 9.5.3.3 New product launches and Innovation;
    • 9.5.4 PRODUCT PORTFOLIO
    • 9.5.5 RECENT DEVELOPMENTS
  • 9.6 ICON, PLC
    • 9.6.1 COMPANY OVERVIEW
    • 9.6.2 FINANCIAL INFORMATION
    • 9.6.3 BUSINESS STRATEGY
      • 9.6.3.1 Business expansion in APAC region
      • 9.6.3.2 Expansion of services offered
      • 9.6.3.3 New product launches and Innovation
    • 9.6.4 PRODUCT PORTFOLIO
    • 9.6.5 RECENT DEVELOPMENTS
  • 9.7 MEDIDATA SOLUTIONS, INC.
    • 9.7.1 COMPANY OVERVIEW
    • 9.7.2 FINANCIAL INFORMATION
    • 9.7.3 BUSINESS STRATEGY
      • 9.7.3.1 New product launches and Innovation
      • 9.7.3.2 Focus on emerging economies
      • 9.7.3.3 Well defined services and initiatives
    • 9.7.4 PRODUCT PORTFOLIO
    • 9.7.5 RECENT DEVELOPMENTS
  • 9.8 INVENTIV HEALTH, INC. (PHARMANET DEVELOPMENT GROUP INC.)
    • 9.8.1 COMPANY OVERVIEW
    • 9.8.2 BUSINESS STRATEGY
      • 9.8.2.1 Expansion through agreements and acquisitions
      • 9.8.2.2 Rebranding subsidiaries
    • 9.8.3 PRODUCT PORTFOLIO
    • 9.8.4 RECENT DEVELOPMENTS
  • 9.9 PIRAMAL LIFE SCIENCES
    • 9.9.1 COMPANY OVERVIEW
    • 9.9.2 FINANCIAL INFORMATION
    • 9.9.3 BUSINESS STRATEGY
      • 9.9.3.1 Expansion of services offered
    • 9.9.4 PRODUCT PORTFOLIO
    • 9.9.5 RECENT DEVELOPMENTS

LIST OF FIGURES

  • FIG. 1 GLOBAL CLINICAL TRIAL SERVICES OUTSOURCING MARKET SHARE, BY CLINICAL TRIALS, 2011 & 2018
  • FIG. 2 COMPARATIVE ANALYSIS OF GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, MARKET SHARE, BY GEOGRAPHY, 2011 & 2018
  • FIG. 3 NORTH AMERICA HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, 20102018 (USD BILLION)
  • FIG. 4 EUROPE CONTRACT RESEARCH OUTSOURCING MARKET, 20102018 (USD BILLION)
  • FIG. 5 ASIA HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, 20102018 (USD BILLION)
  • FIG. 6 REST OF WORLD HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, 20102018 (USD BILLION)
  • FIG. 7 GLOBAL CONTRACT RESEARCH OUTSOURCING MARKET, MARKET SHARE BY KEY PLAYERS 2011 (%)
  • FIG. 8 ANNUAL REVENUE OF QUINTILES TRANSNATIONAL CORPORATION, 20082011 (USD BILLION)
  • FIG. 9 ANNUAL REVENUE OF COVANCE, INC., 20092011 (USD MILLION)
  • FIG. 10 ANNUAL REVENUE OF PPD, INC., 20082010 (USD MILLION)
  • FIG. 11 ANNUAL REVENUE OF PAREXEL INTERNATIONAL CORPORATION, 20092011 (USD MILLION)
  • FIG. 12 ANNUAL REVENUE OF CRL, 2009 - 2011 (USD MILLION)
  • FIG. 13 ANNUAL REVENUE OF ICON, PLC, 2009 - 2011 (USD MILLION)
  • FIG. 14 ANNUAL REVENUE OF MEDIDATA, 2009 - 2011 (USD MILLION)
  • FIG. 15 ANNUAL REVENUE OF PIRAMAL LIFE SCIENCES, 2009 - 2011 (USD MILLION)

LIST OF TABLES

  • TABLE 1 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY GEOGRAPHY, 2010-2018(USD BILLION)
  • TABLE 2 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET REVENUE, BY SERVICES, 20102018 (USD BILLION)
  • TABLE 3 GLOBAL CLINICAL TRIAL SERVICES OUTSOURCING MARKET REVENUE, BY TRIALS, 20102018 (USD BILLION)
  • TABLE 4 GLOBAL CLINICAL TRIAL OUTSOURCING MARKET REVENUE, BY GEOGRAPHY, 2010-2018 (USD BILLION)
  • TABLE 5 GLOBAL REGULATORY SERVICES OUTSOURCING MARKET REVENUE, BY GEOGRAPHY, 2010-2018 (USD BILLION)
  • TABLE 6 GLOBAL MEDICAL WRITING SERVICES OUTSOURCING MARKET REVENUE, BY GEOGRAPHY, 2010-2018 (USD BILLION)
  • TABLE 7 GLOBAL CLINICAL DATA MANAGEMENT OUTSOURCING SERVICES MARKET REVENUE, BY GEOGRAPHY, 2010-2018 (USD BILLION)
  • TABLE 8 GLOBAL OTHER SERVICES OUTSOURCING MARKET REVENUE, BY GEOGRAPHY, 2010-2018 (USD BILLION)
  • TABLE 9 GLOBAL HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET REVENUE, BY DESTINATION RESEARCH GROUPS, 2010-2018 (USD BILLION)
  • TABLE 10 GLOBAL CRO MARKET REVENUE, BY SERVICES, 2010-2018 (USD BILLION)
  • TABLE 11 GLOBAL CLINICAL TRIAL LABORATORIES OUTSOURCING MARKET REVENUE, BY SERVICES, 2010-2018 (USD BILLION)
  • TABLE 12 GLOBAL ACADEMIC MEDICAL CENTERS OUTSOURCING MARKET REVENUE, BY SERVICES, 2010-2018 (USD BILLION)
  • TABLE 13 NORTH AMERICA HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION)
  • TABLE 14 NORTH AMERICA HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION)
  • TABLE 15 NORTH AMERICA CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION)
  • TABLE 16 EUROPE HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION)
  • TABLE 17 EUROPE HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION)
  • TABLE 18 EUROPE CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION)
  • TABLE 19 ASIA HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION)
  • TABLE 20 ASIA HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION)
  • TABLE 21 ASIA CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION)
  • TABLE 22 ROW HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY DESTINATION RESEARCH GROUPS 2010- 2018 (USD BILLION)
  • TABLE 23 ROW HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET, BY SERVICES 2010- 2018 (USD BILLION)
  • TABLE 24 ROW CLINICAL TRIAL OUTSOURCING MARKET, BY CLINICAL TRIALS 2010- 2018 (USD BILLION)
Back to Top